AdaptHealth Corp. (AHCO) — ESG & Values Scores

Environment story

AdaptHealth operates primarily in home medical equipment and healthcare services with no disclosed Scope 1, Scope 2, or Scope 3 emissions data. The company transports compressed and liquid oxygen, which carries inherent safety and environmental risks, but no climate commitments, net-zero targets, or emissions reduction initiatives are disclosed. Environmental risks center on transportation safety hazards and regulatory compliance for medical gas operations rather than decarbonization strategy. The company's risk factors acknowledge climate change risks but provide no mitigation or sustainability programs. Score reflects complete absence of verified environmental disclosures and net-zero commitments, combined with regulatory/safety exposure.

Criticisms on file

Compressed and liquid oxygen transportation risks including ruptures, leaks, fires, personal injury, environmental damage, and property destruction.
Source: AHCO_10k.txt, Risk Factors - Operations and Transportation Hazards
FDA and state regulatory enforcement actions possible; fines, product recalls, injunctions, or operational suspensions could result from non-compliance with cGMP and state regulations at medical gas facilities.
Source: AHCO_10k.txt, Risk Factors - Medical Gas Facility Compliance
Section 232 investigation (Sept 2, 2025) by U.S. Department of Commerce examining imports of personal protective equipment, medical consumables, and medical equipment for national security impact; tariff and regulatory implications pending.
Source: AHCO_10k.txt, Risk Factors - Political and Economic Conditions

Disclosed initiatives

Medical Gas Safety Compliance

AdaptHealth operates medical gas facilities subject to FDA cGMP regulations and state health and safety laws; periodic unannounced inspections and compliance oversight required.

Operational risk mitigation; no emissions reduction impact.

Social story

AdaptHealth discloses minimal workforce diversity, labor relations, or supply-chain ethics data. The company acknowledges 'minimal number of union employees' and notes union activity as a potential labor cost risk factor, but provides no evidence of union suppression. CEO-to-median-worker pay ratio is not disclosed. Diversity metrics for executive and board leadership are absent from the filing. Supply-chain risks (outsourcing to India and Philippines) are acknowledged but no human-rights audits, modern slavery statements, or living-wage commitments are disclosed. Overall, the company exhibits limited transparency on social metrics and ESG programs, with risk management focused narrowly on labor cost inflation and retention rather than worker equity or supply-chain ethics.

Criticisms on file

Outsourcing of billing, administrative, and revenue cycle functions to third-party providers in India and Philippines; risks include non-compliance with requirements, service disruptions, political unrest, labor cost increases, and cyber-attacks.
Source: AHCO_10k.txt, Risk Factors - Outsourcing and Third-Party Providers

Disclosed initiatives

Labor Cost Management and Retention

Company identifies labor shortages and increased competition for talent; uses purchasing power and technology (digital platform) to mitigate cost pressures.

Cost control; no evidence of worker welfare or equity initiatives.

Governance story

AdaptHealth discloses no board independence percentage, share class structure, or detailed lobbying expenditures in the 10-K. The company is subject to multiple federal healthcare fraud and abuse investigations (False Claims Act civil investigative demands from U.S. Attorney's Office for District of South Carolina on July 29, 2024 and Eastern District of Pennsylvania on March 8, 2025) related to billing practices for humidifiers integrated with PAP devices and respiratory devices. These pending investigations represent significant regulatory and financial exposure. The company does not disclose lobbying spending specifically targeting regulatory rollbacks. No evidence of shareholder proposals, antitrust proceedings, or SEC enforcement actions is provided. Governance score reflects regulatory investigation exposure and opaque board/lobbying disclosure.

Criticisms on file

Civil Investigative Demand from U.S. Attorney's Office, District of South Carolina (July 29, 2024) under False Claims Act regarding alleged false claims billing for humidifiers integrated with PAP devices, January 1, 2017 to present. Company cooperating; stage of investigation does not yet permit determination of material adverse effect.
Source: AHCO_10k.txt, Risk Factors - Healthcare Fraud and Abuse Laws
Civil Investigative Demand from U.S. Attorney's Office, Eastern District of Pennsylvania (March 8, 2025) under False Claims Act regarding alleged false claims billing for respiratory devices and supplies, January 1, 2018 to present. Company cooperating; stage of investigation does not yet permit determination of material adverse effect.
Source: AHCO_10k.txt, Risk Factors - Healthcare Fraud and Abuse Laws
Company subject to ongoing governmental audits, investigations, and reviews; prior investigations have resulted in settlements with monetary penalties and compliance/reporting requirements including consent decrees and corporate integrity agreements.
Source: AHCO_10k.txt, Risk Factors - Healthcare Fraud and Abuse Laws

Disclosed initiatives

Fraud and Abuse Compliance

AdaptHealth operates under Anti-Kickback Statute, Stark Law, False Claims Act, and HIPAA regulations; maintains compliance procedures to manage healthcare fraud and abuse risk.

Risk mitigation framework in place; ongoing investigations indicate potential compliance gaps.
Reimbursement and Claims Management

Company operates under Medicare, Medicaid, and private payor reimbursement frameworks; subject to audits by MACs, RACs, UPICs, ZPICs, and OIG.

Compliance required; audit findings can result in overpayment liability and payment suspensions.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of AdaptHealth Corp.. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open AdaptHealth Corp. in the app for interactive charts and portfolio building.

More in Healthcare

Eli Lilly and Company (LLY) Johnson & Johnson (JNJ) AbbVie Inc. (ABBV) UnitedHealth Group Incorporated (UNH) Merck & Co., Inc. (MRK) Thermo Fisher Scientific Inc. (TMO)